I.E.M. GmbH

2014/11/10 10:55

AsiaNet 58572


シュトルベルク(ドイツ)、2014年11月8日/PRニュースワイヤー/ --

脳卒中、腎不全、心臓発作の個人リスクは、高血圧またはコレステロール増加のための治療を開始するかどうかの決定的要因となっています。このリスクは、脈波伝播速度(pulse wave velocity、PWV)を測定することにより、あらゆる早期段階で特定することが可能です。

ドイツ、シュトルベルクに本社を置くIEM社は、Medica(メディカ)2014で、臨床的に検証されたPWVシステム、「Measuring blood pressure and PWV in one (血圧とPWVを一システムで測る)」を発表します。






I.E.M. GmbH


Cockerillstr. 69  

D-52222 Stolberg

電話番号: +49-2402-95-000  

Fax: +49-2402-95-00-11



情報源: I.E.M. GmbH


IEM Innovation Simplifies Risk Management for High Blood Pressure - PWV an Emerging Predictor


STOLBERG, Germany, Nov. 8/PRN=KYODO JBN/--

   The individual risk of stroke, kidney failure and heart attack is the

decisive factor over whether to start treatment for high blood pressure or

increased cholesterol. The risk can be identified at any early stage by

measuring the pulse wave velocity (PWV).

   IEM - based in Stolberg/Germany - will present the clinically validated PWV

system, "Measuring blood pressure and PWV in one", at Medica 2014.

   Scientific data shows that the PWV is an independent predictor for

cardiovascular events and is significantly superior to simply evaluating

traditional risk factors, e.g. increased blood pressure or cholesterol or risk

assessment based on the Framingham risk score.  

   The basic principle of the innovative PWV test method is the combination of

blood pressure measurement and pulse wave analysis. PWV is considered the gold

standard in arterial stiffness evaluation. It is well known that the stiffer

the arteries, the greater the risk of cardiovascular diseases.

   The benefit to patients and medical practitioners is the differentiation

between vascular health and cardiovascular risk. The advantage is that by

measuring the upper-arm blood pressure and PWV in one, a patient can be

classified into "low risk" or "very high risk". This provides to the doctor a

quick and solid basis for taking a decision on treatment.

   The first comprehensive validated test system with the upper-arm cuff is the

Mobil-O-Graph(R), which was validated against invasive catheterisation under

very strict conditions.

   Visit IEM GmbH at Medica from 12th - 15th November 2014 in Hall 9, Stand

C68. Have your blood pressure pulse wave analysis performed.

Contact address for complete article and editing:  

   I.E.M. GmbH

   Cockerillstr. 69

   D-52222 Stolberg

   Tel: +49 2402 95 000

   Fax: +49 2402 95 00 11



   SOURCE: I.E.M. GmbH